Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
---|
01/21/2010 | WO2009137130A3 Antibacterial fluoroquinolone analogs |
01/21/2010 | WO2009046841A8 Piperidine and piperazine derivatives for treating tumours |
01/21/2010 | US20100016299 Substituted benzoxepino-isoxazoles and use thereof |
01/21/2010 | US20100016297 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
01/21/2010 | US20100016287 Compounds having affinity for dopamine d3 receptor and uses thereof" |
01/21/2010 | US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
01/21/2010 | US20100016233 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
01/21/2010 | CA2730843A1 Oxazolopyrimidines as edg-1 receptor agonists |
01/21/2010 | CA2730493A1 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
01/20/2010 | EP2145891A1 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
01/20/2010 | EP2144902A1 [6,6]and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
01/20/2010 | EP2144899A1 Epoxy compound and method for manufacturing the same |
01/20/2010 | EP2144506A1 3-substituted-ý1,2,3¨-benzotriazinone compound for enhancing glutamatergic synaptic responses |
01/20/2010 | CN100582109C Polycyclic agents for the treatment of respiratory syncytial virus infections |
01/19/2010 | USRE41084 Rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methyl propionic acid (CCI-779) and 4-dimethylamino-but-2-enoic acid(4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-ethoxy-quinol in-6-yl)amide (EKB-569); synergistic; antitumor agents |
01/19/2010 | US7649097 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
01/19/2010 | US7648996 39-desmethoxy derivatives of rapamycin |
01/19/2010 | US7648985 Oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
01/19/2010 | US7648980 3-{2-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-8-oxa-3-azabicyclo[3.2.1]oct-6-yl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
01/19/2010 | US7648975 Macrocyclic quinazoline derivatives as antiproliferative agents |
01/19/2010 | CA2402751C Decahydro-isoquinolines |
01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
01/14/2010 | WO2010006191A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
01/14/2010 | WO2010004394A1 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
01/14/2010 | WO2010004304A1 Novel compounds and methods for their production |
01/14/2010 | WO2009121872A3 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
01/14/2010 | US20100009992 Ampk modulators |
01/14/2010 | US20100009982 Modulators of Acetyl-Coenzyme A Carboxylase and Methods of Use Thereof |
01/14/2010 | US20100009980 Novel 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
01/14/2010 | CA2730511A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
01/14/2010 | CA2730377A1 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits |
01/14/2010 | CA2727820A1 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
01/13/2010 | EP1554285B1 Chemical intermediate |
01/13/2010 | CN100579976C P38 inhibitors and methods of use thereof |
01/12/2010 | US7645876 Processes for producing crystalline macrolides |
01/12/2010 | US7645768 Production of polyketides and other natural products |
01/12/2010 | US7645766 Method for treatment of depression and depressive mood disorders |
01/12/2010 | US7645753 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives |
01/07/2010 | WO2010002971A1 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
01/07/2010 | WO2010000817A1 Antitumoral macrolides |
01/07/2010 | WO2010000748A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities |
01/07/2010 | WO2009138734A3 Use of opioid compounds in peripheral pain, wound healing and scar formation |
01/07/2010 | US20100004327 Novel Use of Ansamycin Antibiotics And Method of Screening Novel Angiogenesis Inhibitor |
01/07/2010 | US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
01/07/2010 | CA2731790A1 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
01/07/2010 | CA2729710A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities |
01/07/2010 | CA2729620A1 Antitumoral macrolides |
01/07/2010 | CA2728559A1 Cdk modulators |
01/06/2010 | EP1805278B1 Photochromic h-annellated benzo(f)chrome-derivatives |
01/06/2010 | CN101622259A Spiropiperidine derivatives as NK3 antagonists |
01/06/2010 | CN101622258A Bicyclic oxomorpholine derivative |
01/06/2010 | CN101619068A Novel method for preparing marbofloxacin |
01/06/2010 | CN100577651C Lactam compound and medicinal use thereof |
01/06/2010 | CN100577162C Substituted oxazolidinones for combinational therapy |
01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
01/05/2010 | CA2318889C Insecticidal dihydro-oxadiazines, -thiadiazines and -triazines |
12/31/2009 | US20090326221 New oxabispidine compunds useful in the treatment of cardiac arrhythmias |
12/31/2009 | US20090325946 Novel phenolic and catecholic amines and prodrugs thereof |
12/31/2009 | US20090325929 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
12/31/2009 | US20090324625 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
12/30/2009 | WO2009157505A1 Telomerase inhibitor |
12/30/2009 | WO2009156458A1 Novel phenolic and catecholic amines and prodrugs thereof |
12/30/2009 | WO2009108730A3 Forms of rifaximin and uses thereof |
12/30/2009 | EP2137193A2 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof |
12/30/2009 | EP1608632B1 Quinazolines useful as modulators of ion channels |
12/30/2009 | EP1490047B1 Certain pharmaceutically useful substituted aminoalkyl heterocycles |
12/30/2009 | EP0804561B1 Regulated transcription of targeted genes and other biological events |
12/29/2009 | US7638531 use in treating inflammatory diseases, allergic conditions, diabetes, obesity, an obesity-related disorder, metabolic syndrome, a cognition deficit disorder, cardiovascular and central nervous system disorders |
12/29/2009 | US7638530 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents |
12/29/2009 | US7638529 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
12/29/2009 | CA2429440C Dehalogeno-compounds |
12/24/2009 | US20090318687 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds |
12/24/2009 | US20090318436 Fused heterocyclic derivatives and methods of use |
12/24/2009 | US20090318421 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity |
12/24/2009 | US20090318412 Tricyclic heterocyclic compound and use thereof |
12/24/2009 | US20090318373 Receptor-type kinase modulators and methods of use |
12/23/2009 | WO2009155017A2 Novel substituted azabenzoxazoles |
12/23/2009 | EP2134717A2 Inhibitors of serine proteases |
12/23/2009 | EP2134693A2 Metalloprotease inhibitors containing a heterocyclic moiety |
12/23/2009 | EP1720859B1 Chemokine receptor antagonists |
12/23/2009 | EP1682550B1 Substituted naphthyridinone derivatives |
12/23/2009 | EP1420787B1 Ophthalmic composition comprising an ascomycin |
12/23/2009 | CN101611039A HCV NS3 protease inhibitors |
12/23/2009 | CN101611038A 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
12/23/2009 | CN101610771A Therapeutic agent for liver cancer |
12/23/2009 | CA2727928A1 Inhibitors of janus kinases |
12/23/2009 | CA2725940A1 Novel substituted azabenzoxazoles |
12/22/2009 | CA2535614C Quinazoline analogs as receptor tyrosine kinase inhibitors |
12/22/2009 | CA2475383C Method for extracting a macrolide from biomatter |
12/22/2009 | CA2405593C Macrolides |
12/22/2009 | CA2290744C Cyclic diamine compounds and medicine containing the same |
12/22/2009 | CA2262435C Preparation of sterically hindered amine ethers |
12/17/2009 | WO2009149836A1 Annellated 4- (indazolyl) -1,4-dihydropyridine derivatives and methods of use thereof |
12/17/2009 | WO2009149820A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
12/17/2009 | WO2009116801A3 Caspase inhibitor prodrug |
12/17/2009 | WO2009091374A3 Fused heterocyclic derivatives and methods of use as c-met inhibitors |
12/17/2009 | WO2008144931A8 Compositions and methods for modulating gated ion channels |
12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
12/17/2009 | US20090312312 Heterobicyclic Metalloprotease Inhibitors |